Tenaya Therapeutics, Inc.TNYANASDAQ
Loading
Operating Income Growth Under PressureDecelerating
Percentile Rank57
5Y CAGR-9.2%
Year-over-Year Change
Year-over-year operating income growth rate
5Y CAGR
-9.2%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
0.6x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 0.77% |
| Q3 2025 | 13.06% |
| Q2 2025 | 12.55% |
| Q1 2025 | -11.71% |
| Q4 2024 | 7.71% |
| Q3 2024 | 13.34% |
| Q2 2024 | 8.71% |
| Q1 2024 | -7.37% |
| Q4 2023 | -1.70% |
| Q3 2023 | 11.92% |
| Q2 2023 | -4.10% |
| Q1 2023 | 2.39% |
| Q4 2022 | -10.39% |
| Q3 2022 | -9.36% |
| Q2 2022 | 8.14% |
| Q1 2022 | -19.07% |
| Q4 2021 | -42.97% |
| Q3 2021 | -20.10% |
| Q2 2021 | -16.27% |
| Q1 2021 | -26.96% |
| Q4 2020 | 1.24% |
| Q3 2020 | -17.81% |
| Q2 2020 | 4.25% |
| Q1 2020 | 0.00% |